Gish R - Search Results

1

Hepatitis C virus as a systemic disease: reaching beyond the liver.

Gill K, Ghazinian H, Manch R, Gish R. Gill K, et al. Among authors: gish r. Hepatol Int. 2016 May;10(3):415-23. doi: 10.1007/s12072-015-9684-3. Epub 2015 Dec 10. Hepatol Int. 2016. PMID: 26660706 Free PMC article. Review.

2

Survival after liver transplantation for chronic hepatitis B using reduced immunosuppression.

Gish RG, Keeffe EB, Lim J, Brooks LJ, Esquivel CO. Gish RG, et al. J Hepatol. 1995 Mar;22(3):257-62. doi: 10.1016/0168-8278(95)80276-2. J Hepatol. 1995. PMID: 7608474

3

Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.

Cacciarelli TV, Martinez OM, Gish RG, Villanueva JC, Krams SM. Cacciarelli TV, et al. Among authors: gish rg. Hepatology. 1996 Jul;24(1):6-9. doi: 10.1002/hep.510240102. Hepatology. 1996. PMID: 8707283 Free article. Clinical Trial.

4

Safety and antiviral activity of emtricitabine (FTC) for the treatment of chronic hepatitis B infection: a two-year study.

Gish RG, Trinh H, Leung N, Chan FK, Fried MW, Wright TL, Wang C, Anderson J, Mondou E, Snow A, Sorbel J, Rousseau F, Corey L. Gish RG, et al. J Hepatol. 2005 Jul;43(1):60-6. doi: 10.1016/j.jhep.2005.02.017. Epub 2005 Apr 11. J Hepatol. 2005. PMID: 15922478 Clinical Trial.

5

Liver disease in Viet Nam: screening, surveillance, management and education: a 5-year plan and call to action.

Gish RG, Bui TD, Nguyen CT, Nguyen DT, Tran HV, Tran DM, Trinh HN; International Group for Liver Health in Viet Nam. Gish RG, et al. J Gastroenterol Hepatol. 2012 Feb;27(2):238-47. doi: 10.1111/j.1440-1746.2011.06974.x. J Gastroenterol Hepatol. 2012. PMID: 22098550 Review.

6

Immunosuppression in Patients with Chronic Hepatitis B.

Seetharam A, Perrillo R, Gish R. Seetharam A, et al. Among authors: gish r. Curr Hepatol Rep. 2014 Jun 21;13(3):235-244. doi: 10.1007/s11901-014-0238-2. eCollection 2014. Curr Hepatol Rep. 2014. PMID: 25101233 Free PMC article. Review.

7

High rate of core promoter and precore mutations in patients with chronic hepatitis B.

Baqai SF, Proudfoot J, Yi DH, Mangahas M, Gish RG. Baqai SF, et al. Hepatol Int. 2015 Apr;9(2):209-17. doi: 10.1007/s12072-014-9598-5. Epub 2014 Dec 25. Hepatol Int. 2015. PMID: 25788186 Free PMC article.

8

Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States.

Gish RG, Cohen CA, Block JM, Brosgart CL, Block TM, Clary R, Le LT, Ninburg MH, Sandt L, Kowdley KV. Gish RG, et al. Hepatology. 2015 Nov;62(5):1339-41. doi: 10.1002/hep.28026. Epub 2015 Sep 29. Hepatology. 2015. PMID: 26239816 Free PMC article. No abstract available.

9

Chronic hepatitis B virus in the Philippines.

Gish RG, Sollano JD Jr, Lapasaran A, Ong JP. Gish RG, et al. J Gastroenterol Hepatol. 2016 May;31(5):945-52. doi: 10.1111/jgh.13258. J Gastroenterol Hepatol. 2016. PMID: 26643262 Review.

10

Defining the possibilities: is short duration treatment of chronic hepatitis C genotype 1 with sofosbuvir-containing regimens likely to be as effective as current regimens?

Nafisi S, Roy S, Gish R, Manch R, Kohli A. Nafisi S, et al. Among authors: gish r. Expert Rev Anti Infect Ther. 2016;14(1):41-56. doi: 10.1586/14787210.2016.1114883. Epub 2015 Dec 14. Expert Rev Anti Infect Ther. 2016. PMID: 26654939 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

345 results

Search Page